Raffles Medical: Grp announced results which was inline with consensus, posting 3Q10 rev of $60.9m up 9.8% YoY while PATMI was at $10.7m, up 12.9% YoY. Record revenue was reached in 3Q10 as all divisions posted healthy increase in rev as demand for healthcare services rose and operating efficiency increased, with EBIT margins up 21.5% YoY…
CIMB has Outperform rating on stock and Technical Buy Call, noting that prices are sitting just above its support trend line as well as its 50-day SMA, and there is a chance that prices might rebound if prices continue to hold above these support levels, however note that prices need to hold above the $2.16 level for any chance to retest high of $2.37. Break below $2.16 would see prices fall towards $2.00…
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment